Longevity EvidenceNon-commercial
APOE4 Systemically Disrupts Cholesterol Transport and Reduces Myelination via Oligodendrocyte Dysfunction; ABCA7 Loss-of-Function Disrupts Phosphatidylcholine Metabolism and Mitochondrial Function in Neurons
Recent Nature publications (2022, 2025) suggest Alzheimer's genetic risk alleles APOE4 and ABCA7 LoF disrupt brain lipid maintenance over decades through distinct but converging pathways (cholesterol transport → oligodendrocyte myelination; phospholipid flipping → neuronal membra
- Type
- evidence-claim
- Domain
- h03_epigenetic_alterations
- Grade
- B
- License
- CC BY-NC 4.0
- card_id
- L-007
- hallmarks
- h03_epigenetic_alterations,h04_loss_of_proteostasis,h07_mitochondrial_dysfunction
- cluster
- science_layer
- primary_disease_area
- alzheimers,longevity_general
- evidence_tier
- B
- evidence_anchor_count
- 5
- intake_round
- R23
- intake_date
- 2026-05-26
- related_experts
- TBD-Blanchard,TBD-vonMaydell,TBD-Tsai
- related_biomarkers
- bm_ptau217_abeta42_ratio
- related_interventions
- related_trials
- collection_pages
- /research/mechanisms,/research/alzheimers-risk-biology
LongProof Longevity Dynamic · LIGHT HOPE / x1000.ai · longevity.x1000.ai · 2026 · source
Read-only aggregated view. Longevity Evidence is the source of record; this catalog shows provenance as-is — no ratings, no reviews.